BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 16316457)

  • 1. Small cyclic agonists of iron regulatory hormone hepcidin.
    Chua K; Fung E; Micewicz ED; Ganz T; Nemeth E; Ruchala P
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4961-4969. PubMed ID: 25813158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and binding properties of cyclohexapeptide somatostatin analogs containing naphthylalanine and arylalkyl peptoid residues.
    Tran TA; Mattern RH; Morgan BA; Taylor JE; Goodman M
    J Pept Sci; 1999 Mar; 5(3):113-30. PubMed ID: 10323556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational analyses of cyclic hexapeptide analogs of somatostatin containing arylalkyl peptoid and naphthylalanine residues.
    Mattern RH; Tran TA; Goodman M
    J Pept Sci; 1999 Apr; 5(4):161-75. PubMed ID: 10323196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues.
    Tran TA; Mattern RH; Afargan M; Amitay O; Ziv O; Morgan BA; Taylor JE; Hoyer D; Goodman M
    J Med Chem; 1998 Jul; 41(15):2679-85. PubMed ID: 9667958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bioactive somatostatin analog without a type II' beta-turn: synthesis and conformational analysis in solution.
    Jiang S; Gazal S; Gelerman G; Ziv O; Karpov O; Litman P; Bracha M; Afargan M; Gilon C; Goodman M
    J Pept Sci; 2001 Oct; 7(10):521-8. PubMed ID: 11695647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and binding potencies of cyclic hexapeptide analogs of somatostatin incorporating acidic and basic peptoid residues.
    Tran TA; Mattern RH; Morgan BA; Taylor JE; Goodman M
    J Pept Res; 1999 Feb; 53(2):134-45. PubMed ID: 10195451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biologic activity of conformationally constrained analogs of L-363,301.
    Moore SB; Grant M; Rew Y; Bosa E; Fabbri M; Kumar U; Goodman M
    J Pept Res; 2005 Dec; 66(6):404-22. PubMed ID: 16316457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational and topographical considerations in the design of biologically active peptides.
    Hruby VJ
    Biopolymers; 1993 Jul; 33(7):1073-82. PubMed ID: 8102072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of conformationally restricted analogues of bradykinin and somatostatin using constrained amino acids and different types of cyclization.
    Reissmann S; Imhof D
    Curr Med Chem; 2004 Nov; 11(21):2823-44. PubMed ID: 15544478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.
    Seebach D; Beck AK; Bierbaum DJ
    Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrates in peptide and protein design.
    Jensen KJ; Brask J
    Biopolymers; 2005; 80(6):747-61. PubMed ID: 15929028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cyclization of peptides and depsipeptides.
    Davies JS
    J Pept Sci; 2003 Aug; 9(8):471-501. PubMed ID: 12952390
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.